TOSYY yields 13.40% · JNJ yields 2.13%● Live data
📍 TOSYY pulled ahead of the other in Year 1
Combined, TOSYY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TOSYY + JNJ for your $10,000?
Toshiba Corporation, together with its subsidiaries, provides electronic devices and storage solutions worldwide. It operates through Energy Systems and Solutions, Infrastructure Systems and Solutions, Building Solutions, Retail and Printing Solutions, Electronic Devices and Storage Solutions, Digital Solutions, and Other segments. The company provides energy systems and solutions, including nuclear, thermal, and renewable energy power generation systems; transmission and distribution, hydro, geothermal, solar, and wind power services. It also offers infrastructure systems and solutions, such as water supply, sewerage, waste, subways, railways, airports, road, and ports service; security and automation, and motor/drive systems, equipment, facilities, maintenance services; telecommunication, power distribution, communication, and broadcast systems. In addition, the company provides building solutions comprising light fixtures, industrial light parts, commercial air-conditioner compressors, elevators, escalators for buildings and facilities, ventilation, and lighting, as well as energy-saving, environmentally products and services, and building solutions for security. Further, the company offers power, small-signal, and optoelectronic devices, In-vehicle digital and logic microcomputers, analog ICs, semiconductor manufacturing equipment , and parts materials. Additionally, it provides automotive, industrial semiconductors, manufacturing equipment, battery systems, and IT solution services. Toshiba Corporation was founded in 1875 and is headquartered in Tokyo, Japan.
Full TOSYY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.